Patent · US Active

Human cytomegalovirus RNA vaccines

US10064935B2 · kind B2 · utility

112Cited by
12References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 11, 2017
Grant dateSep 4, 2018
Priority date—
Expiry dateAug 11, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2710/16171
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The disclosure describes HCMV ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.